Multi-Site Harmonization of TBNK Cell Frequencies on the ACCELLIX™ Platform: A Nested ANOVA Across Instruments, Sites, Reagent Lots, and Operators
Explore how the ACCELLIX™ Platform enables standardized, automated phenotyping of cryopreserved leukapheresis samples across multiple collection sites. This study demonstrates high precision and reproducibility for key TBNK cell population measurements, supporting reliable quality assessment in decentralized cell and gene therapy environments.
Download the Scientific Poster
- Filename
- ACCELLIX_CAR TCR 2026 Poster.pdf
- Size
- 2 MB
- Format
- application/pdf
Summary:
- Evaluates the reproducibility of leukapheresis sample characterization across three independent collection sites using cryopreserved samples.
- Assesses variability across instruments, operators, and reagent lots, demonstrating consistent cell frequency measurements in a decentralized testing environment.
- Highlights the potential for standardized, automated immune cell profiling to support harmonized quality assessment in cell and gene therapy workflows.
FEATURED SOLUTION
Want to discuss your needs?
Complete the form below to get in touch with our team. A bioMérieux expert will be in touch using the contact information you provide. By providing your information, you agree to receive additional emails from bioMérieux about cell and gene therapy quality control.
To find out more about the management of your personal data and to exercise your rights, see our privacy policy.